» Articles » PMID: 25853653

Cerebrospinal Fluid Cytokine Profiles Predict Risk of Early Mortality and Immune Reconstitution Inflammatory Syndrome in HIV-associated Cryptococcal Meningitis

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2015 Apr 9
PMID 25853653
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the host immune response during cryptococcal meningitis (CM) is of critical importance for the development of immunomodulatory therapies. We profiled the cerebrospinal fluid (CSF) immune-response in ninety patients with HIV-associated CM, and examined associations between immune phenotype and clinical outcome. CSF cytokine, chemokine, and macrophage activation marker concentrations were assayed at disease presentation, and associations between these parameters and microbiological and clinical outcomes were examined using principal component analysis (PCA). PCA demonstrated a co-correlated CSF cytokine and chemokine response consisting primarily of Th1, Th2, and Th17-type cytokines. The presence of this CSF cytokine response was associated with evidence of increased macrophage activation, more rapid clearance of Cryptococci from CSF, and survival at 2 weeks. The key components of this protective immune-response were interleukin (IL)-6 and interferon-γ, IL-4, IL-10 and IL-17 levels also made a modest positive contribution to the PC1 score. A second component of co-correlated chemokines was identified by PCA, consisting primarily of monocyte chemotactic protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α). High CSF chemokine concentrations were associated with low peripheral CD4 cell counts and CSF lymphocyte counts and were predictive of immune reconstitution inflammatory syndrome (IRIS). In conclusion CSF cytokine and chemokine profiles predict risk of early mortality and IRIS in HIV-associated CM. We speculate that the presence of even minimal Cryptococcus-specific Th1-type CD4+ T-cell responses lead to increased recruitment of circulating lymphocytes and monocytes into the central nervous system (CNS), more effective activation of CNS macrophages and microglial cells, and faster organism clearance; while high CNS chemokine levels may predispose to over recruitment or inappropriate recruitment of immune cells to the CNS and IRIS following peripheral immune reconstitution with ART. These results provide a rational basis for future studies of immune modulation in CM, and demonstrate the potential of baseline immune profiling to identify CM patients most at risk of mortality and subsequent IRIS.

Citing Articles

iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis.

Zhao J, Fang W, Gao Y, Chen J, Wang G, Gu J Front Microbiol. 2025; 16:1531425.

PMID: 39996080 PMC: 11847882. DOI: 10.3389/fmicb.2025.1531425.


Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis.

Zhao J, Lin B, Luo C, Yi Y, Huang P, Chen Y J Transl Med. 2024; 22(1):1000.

PMID: 39501324 PMC: 11539571. DOI: 10.1186/s12967-024-05794-4.


Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda.

Kasibante J, Irfanullah E, Wele A, Okafor E, Ssebambulidde K, Okurut S Med Mycol. 2024; 62(10).

PMID: 39419774 PMC: 11520412. DOI: 10.1093/mmy/myae101.


Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis.

Okafor E, Mukaremera L, Hullsiek K, Engen N, Tugume L, Ssebambulidde K J Infect Dis. 2024; 231(2):521-531.

PMID: 39207255 PMC: 11841645. DOI: 10.1093/infdis/jiae421.


Mechanisms and Virulence Factors of Dissemination to the Central Nervous System.

Al-Huthaifi A, Radman B, Al-Alawi A, Mahmood F, Liu T J Fungi (Basel). 2024; 10(8).

PMID: 39194911 PMC: 11355766. DOI: 10.3390/jof10080586.


References
1.
Jarvis J, Harrison T . HIV-associated cryptococcal meningitis. AIDS. 2007; 21(16):2119-29. DOI: 10.1097/QAD.0b013e3282a4a64d. View

2.
Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A . High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. 2008; 47(1):123-30. DOI: 10.1086/588792. View

3.
Hardison S, Herrera G, Young M, Hole C, Wozniak K, Wormley Jr F . Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012; 189(8):4060-8. PMC: 3466339. DOI: 10.4049/jimmunol.1103455. View

4.
Aguirre K, Miller S . MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection. Glia. 2002; 39(2):184-8. DOI: 10.1002/glia.10093. View

5.
Brouwer A, Rajanuwong A, Chierakul W, Griffin G, Larsen R, White N . Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004; 363(9423):1764-7. DOI: 10.1016/S0140-6736(04)16301-0. View